OOIR: Observatory of International Research

Papers

(The TQCC of Journal of the Peripheral Nervous System is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
	65
	46
Abstracts	38
	30
Identifying Predictors of Idiopathic Small‐Fiber Neuropathy in Adolescent Patients With Chronic Pain	26
Safety and Cost Analysis of Immunoglobulin Cessation Trials in Chronic Inflammatory Demyelinating Polyradiculoneuropathy	23
Broadening Research Priorities in Peripheral Neuropathy: A Response to “A Call to Action for Peripheral Neuropathy Research Funding—Time to Consolidate Funding Under One NIH Initiative?”	23
PNS Abstracts 2023	21
Toxic medications in Charcot–Marie–Tooth patients: A systematic review	19
	18
Nerve ultrasound as a screening tool for inherited sensory neuronopathy	16
Abstracts of the 33rd annual meeting of the Japanese peripheral nerve society (JPNS)	16
Genetic, electrophysiological, and pathological studies on patients with SCN9A‐related pain disorders	15
Corneal confocal microscopy in small and mixed fiber neuropathy—Comparison with skin biopsy and cold detection in a large prospective cohort	15
Ofatumumab for treating autoimmune nodopathy	15
Incidence and risk factors for developing chemotherapy‐induced neuropathic pain in 500 cancer patients: A file‐based observational study	14
Variability in Conduction Block Definitions Affects the Sensitivity of Diagnostic Criteria for Multifocal Motor Neuropathy	14
Loss of MEGF10 Decreases the Number of Perisynaptic Schwann Cells and Innervation of Neuromuscular Junctions in Aging Mice	14
Feasibility, Validity, and Reliability of the Virtual CMT Infant Toddler Scale (vCMTInfS): A Remote Evaluation of Infants/Toddlers With CMT	14
Issue Information	13
Conduction slowing, conduction block and temporal dispersion in demyelinating, dysmyelinating and axonal neuropathies: Electrophysiology meets pathology	12
Assessing corneal dendritic cells in glucose dysregulation small‐fibre neuropathy	12
Effectiveness of exercise therapy for individuals diagnosed with Charcot–Marie–Tooth disease: A systematic review of randomized clinical trials	12
Long read sequencing overcomes challenges in the diagnosis of SORD neuropathy	12
Abstracts of the 35th Annual Meeting of the Japanese Peripheral Nerve Society (JPNS)	12

Parent‐proxy pediatric CMT quality of life outcome measure: Validation of the Italian version	11
A robust framework for characterising diffusion metrics of the median and ulnar nerves: Exploiting state‐of‐the‐art tracking methods	11
Issue Information	11
Association of dynamic hepatic metabolism with clinical outcomes in patients with severe Guillain‐Barré syndrome: A prospective cohort study from multi‐centers in China	11
Pain hypersensitivity, sensorimotor impairment, and decreased muscle force in a novel rat model of radiation‐induced peripheral neuropathy	11
Techniques for the standard histological and ultrastructural assessment of nerve biopsies	10
Issue Information	10
Benefit of high‐dose oral riboflavin therapy in riboflavin transporter deficiency	10
Patient‐reported disease burden in the Accelerate Clinical Trials in Charcot–Marie–Tooth Disease Study	10
A Novel Case of Nerve Biopsy Proven Wild Type Transthyretin (TTR) Amyloidosis	10
IgM anti‐MAG^± peripheral neuropathy (IMAGiNe) study protocol: An international, observational, prospective registry of patients with IgM M‐protei	10
Disease‐specific wearable sensor algorithms for profiling activity, gait, and balance in individuals with Charcot–Marie–Tooth disease type 1A	9
Peripheral neuropathy as clinical onset of monoclonal IgM/k‐related amyloidosis	9
Diagnostic and clinical utility of comprehensive multigene panel testing for patients with neuropathy	9
Dapagliflozin for Small Nerve Fibre Regeneration in Diabetic Peripheral Neuropathy: A Randomised Controlled Study (DINE)	8
	8
Issue Information	8
Chronic inflammatory demyelinating polyradiculoneuropathy: Diagnostic problems in clinical practice in Serbia	8
	8
European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision	8
Issue Information	8
Issue Information	8
Glucose‐lowering medication associated with weight loss may limit the progression of diabetic neuropathy in type 2 diabetes	8
An innovative phase 2 proof‐of‐concept trial design to evaluate SAR445088, a monoclonal antibody targeting complement C1s in chronic inflammatory demyelinating polyneuropathy	7
A novel de novo variant in POLR3B gene associated with a primary axonal involvement of the largest nerve fibers	7
Issue Information	7
Intravenous Immunoglobulin Elevates Regulatory T Cells in Guillain‐Barré Syndrome: A Potential Biomarker of Therapeutic Response	7
The autoimmune vulnerability of the node of Ranvier	6
Clinical and genetic features of CMT2T in Italian patients confirm the importance of MME pathogenic variants in idiopathic, late‐onset axonal neuropathies	6
Reply to “Nerve ultrasound as a screening tool for inherited sensory neuronopathy”	6
	6
Validation of an Artificial Intelligence driven framework to automatically detect red flag symptoms in screening for rare diseases in electronic health records: hereditary transthyretin amyloidosis po	6
ABSTRACT	6
	6
Digenesis in Charcot–Marie–Tooth Disease: Impact of Combined Mutations in the MFN2 and GDAP1 Genes	5
Correction to “Polyneuropathy in Kidney Transplant Recipients: Accuracy of a New Clinical Diagnostic Scoring System”	5
Serum neurofilament light chain as a reliable biomarker of hereditary transthyretin‐related amyloidosis—A Swiss reference center experience	5
Influence of Genomic Ancestry and Other Traditional Risk Factors on the Prevalence of Diabetic Peripheral Neuropathy in Admixed Individuals With Type 1 Diabetes in Brazil: A Pioneer Multicenter Study	5
	5
Acquired Transthyretin Amyloidosis in Domino Liver Transplantation Treated With Gene‐Silencers	5
The small fiber neuropathy—symptom inventory questionnaire (SFN‐SIQ) does not discriminate between patients with or without small fiber neuropathy	5
VitaminB6levels do not correlate with severity of neuropathy in chronic idiopathic axonal polyneuropathy	5
Anxiety and depression in small fiber neuropathy	4
Automated immunohistochemistry of intra‐epidermal nerve fibres in skin biopsies: A proof‐of‐concept study	4
Issue Information	4
Issue Information	4
Clinical and Electrophysiological Characterization of Diabetic Neuropathy in a Sub‐Saharan African Cohort	4
Cytokines and chemokines in patients with chronic inflammatory demyelinating polyradiculoneuropathy and multifocal motor neuropathy: A systematic review	4
GDAP1‐Related Charcot–Marie–Tooth Disease: Axonal or Demyelinating Subtype? Autosomal Recessive or Autosomal Dominant Inheritance?	4
Do corticosteroids aggravate pure motor chronic inflammatory demyelinating polyneuropathy?	4

Predicting long‐term trends in inflammatory neuropathy outcome measures using latent class modelling	4
Cutaneous biomarkers of therapeutic efficacy in early treatment of hereditary ATTR amyloid polyneuropathy with tafamidis	4
Assessing deterioration using impairment and functional outcome measures in chronic inflammatory demyelinating polyneuropathy: A post‐hoc analysis of the immunoglobulin overtreatment in CIDP trial	4
Diagnostic value of nerve conduction study in NOTCH2NLC‐related neuronal intranuclear inclusion disease	4
High‐Fat Diet Disrupt Nerve Function by Targeting Schwann Cells	4
INF2 mutations in patients with a broad phenotypic spectrum of Charcot‐Marie‐Tooth disease and focal segmental glomerulosclerosis	4
COVID‐19 and the peripheral nervous system. A 2‐year review from the pandemic to the vaccine era	4
Genetic and Clinical Features of 10 Families With Hereditary Sensory Neuropathies	4
Macrophages influence Schwann cell myelin autophagy after nerve injury and in a model of Charcot‐Marie‐Tooth disease	4